ONCOLYTICS BIOTECH INC's ticker is ONCYF and the CUSIP is 682310107. A total of 6 filers reported holding ONCOLYTICS BIOTECH INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $0 | – | 335 | 0.0% | 0.00% | – |
| Q2 2015 | $0 | – | 335 | 0.0% | 0.00% | – |
| Q1 2015 | $0 | -100.0% | 335 | -68.1% | 0.00% | – |
| Q4 2014 | $1,000 | -99.9% | 1,050 | -99.9% | 0.00% | -100.0% |
| Q3 2014 | $828,000 | -77.2% | 1,447,950 | -48.8% | 0.00% | -72.7% |
| Q2 2014 | $3,629,000 | -26.1% | 2,826,250 | 0.0% | 0.01% | -35.3% |
| Q1 2014 | $4,909,000 | +16.1% | 2,826,250 | +4.5% | 0.02% | +6.2% |
| Q4 2013 | $4,227,000 | -35.1% | 2,704,900 | +0.8% | 0.02% | -44.8% |
| Q3 2013 | $6,514,000 | -8.3% | 2,684,000 | +8.6% | 0.03% | -6.5% |
| Q2 2013 | $7,100,000 | – | 2,471,300 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SOPHROSYNE CAPITAL LLC | 222,900 | $345,000 | 0.30% |
| ACUITY INVESTMENT MANAGEMENT INC | 69,300 | $108,000 | 0.04% |
| VSR Financial Services, Inc. | 357,770 | $554,000 | 0.04% |
| 1832 Asset Management L.P. | 2,704,900 | $4,227,000 | 0.02% |
| Paradigm Financial Advisors, LLC | 9,558 | $15,000 | 0.02% |
| AGF INVESTMENTS INC. | 860,749 | $1,345,000 | 0.01% |
| BANK OF MONTREAL /CAN/ | 1,833,669 | $2,842,000 | 0.00% |
| BANK OF NOVA SCOTIA | 500,000 | $781,000 | 0.00% |
| RUSSELL FRANK CO/ | 1,005,900 | $1,553,000 | 0.00% |
| First Eagle Investment Management, LLC | 427,200 | $662,000 | 0.00% |